NV

Envista Holdings CorpNYSE NVST Stock Report

Last reporting period 28 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

3.267

Middle

Exchange

XNYS - New York Stock Exchange, Inc

NVST Stock Analysis

NV

Uncovered

Envista Holdings Corp is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-12/100

Low score

Market cap $B

3.267

Dividend yield

Shares outstanding

163.23 B

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,700 full-time employees. The company went IPO on 2019-09-18. The firm provides dental consumables, solutions, technology, and services. The company has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The firm operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

View Section: Eyestock Rating